Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;11(4):414–421. doi: 10.1111/j.1750-3639.2001.tb00409.x

4‐Hydroxynonenal Immunoreactivity is Increased in Human Hippocampus After Global Ischemia

Eileen McCracken 1,✉, David I Graham 2, Margaret Nilsen 2, Janice Stewart 1, James AR Nicoll 1, Karen Horsburgh 1,2
PMCID: PMC8098262  PMID: 11556686

Abstract

Oxidative stress and lipid peroxidation may contribute to the pathology of neurodegenerative disorders such as Alzheimer's disease (AD) and cerebral ischemia. 4‐Hydroxynonenal (4‐HNE) is a toxic byproduct of lipid peroxidation, and immunoreactivity to 4‐HNE has been used to examine lipid peroxidation in the pathogenesis of AD and ischemia. This study sought to determine 1) if there are cellular alterations in 4‐HNE immunoreactivity in the human hippocampus after global ischemia, and 2) whether possession of an apolipoprotein E (APOE) ε4 allele influenced the extent of 4‐HNE immunoreactivity. 4‐HNE immunoreactivity was assessed semi‐quantitatively in the temporal lobe of a group of controls (n = 44) and in a group of patients who had an episode of global ischemia as a result of a cardiorespiratory arrest and subsequently died (n = 56, survival ranged from 1hr to 42days). There was minimal cellular 4‐HNE immunoreactivity in the control group. However, compared to controls, 4‐HNE immunoreactivity was significantly increased in neurons (p<0.0002) and glia (p<0.0001) in the hippocampal formation after global ischemia. Possession of an APOEε4 allele did not influence the extent of neuronal or glial 4‐HNE immunostaining in the control or global ischemia group. There was a significant negative correlation between the extent of neuronal 4‐HNE immunoreactivity with survival period after global ischemia (r2= 0.0801; p<0.036) and a significant positive correlation between the extent of glial 4‐HNE immunoreactivity and survival after global ischemia (r2= 0.2958; p<0.0001). The data indicate a marked increase in neuronal and glial 4‐HNE. This substantiates a role for lipid peroxidation in the pathogenesis of cerebral ischemia. There was no indication that APOE genotype influenced the extent of 4‐HNE immunoreactivity.

Full Text

The Full Text of this article is available as a PDF (252.2 KB).

References

  • 1. Ando Y, Brannstrom T, Uchida K, Nylin N, Nasman B, Suhr O, Yamashita T, Olsson T, Salhy ME, Uchino M, Ando M (1998) Histochemical detection of 4‐hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci 156: 172–176. [DOI] [PubMed] [Google Scholar]
  • 2. Blanc EM, Keller JN, Fernandez S, Mattson MP (1998) 4‐Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 22: 149–160. [DOI] [PubMed] [Google Scholar]
  • 3. Bruce‐Keller AJ, Li Y‐J, Lovell MA, Kraemer PJ, Gary DS, Brown RR, Markesbery WR, Mattson MP (1998) 4‐Hydroxynonenal, a product lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropath Exp Neurol 57: 257–267. [DOI] [PubMed] [Google Scholar]
  • 4. Comporti M (1985) Biology of disease lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 53: 599–623. [PubMed] [Google Scholar]
  • 5. Comporti M (1989) Three models of free radical induced cell injury. Chem Biol Interact 72: 1–56. [DOI] [PubMed] [Google Scholar]
  • 6. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4‐hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 11: 81–128. [DOI] [PubMed] [Google Scholar]
  • 7. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso J, Johnson GV (1996) Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal protein. Exp Neurol 138: 252–260. [DOI] [PubMed] [Google Scholar]
  • 8. Friguet B, Stadtman ER, Sweda LI (1994) Modification of glucose‐6‐phosphate dehydrogenase by 4‐hydroxynonenal. J Biol Chem 269: 21639–21643. [PubMed] [Google Scholar]
  • 9. Hayek T, Oiknine, Brook JG, Aviram M (1994) Increased plasma and lipoprotein lipid peroxidation in apoE‐deficient mice. Biochem Biophys Res Commun 201: 1567–1574. [DOI] [PubMed] [Google Scholar]
  • 10. Horsburgh K, McCulloch J, Nilsen M, McCracken E, Large C, Roses AD, Nicoll JAR (2000) Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J Cereb Blood Flow Met 20:458–462. [DOI] [PubMed] [Google Scholar]
  • 11. Horsburgh K, Graham DI, Stewart J, Nicoll JAR (1999) Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J Neuropath Exp Neurol 58:227–234. [DOI] [PubMed] [Google Scholar]
  • 12. Karlbuber GM, Bauer HC, Eckl PM (1997) Cytotoxic and genotoxic effects of 4‐hydroxynonenal in cerebral endothethial cells. Mutation Res 381: 209–216. [DOI] [PubMed] [Google Scholar]
  • 13. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP (1997) 4‐Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80: 685–696. [DOI] [PubMed] [Google Scholar]
  • 14. Kinter M, Roberts RJ (1996) Glutathione consumption and glutathione peroxidase inactivation in fibroblast cell lines by 4‐hydroxynon‐2‐nenal. Free Radical Biol Med 21: 457–462. [DOI] [PubMed] [Google Scholar]
  • 15. Lomnitski L, Chapman S, Hochman A, Kohen R, Shohami E, Chen Y, Trembovler V, Michaelson DM (1999) Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim Biophys Acta 1453: 359–368. [DOI] [PubMed] [Google Scholar]
  • 16. Love S (1999) Symposium: Oxidative stress in Neurological disease. Brain Pathol 9: 119–131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR (1997) Elevated 4‐hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 18: 457–461. [DOI] [PubMed] [Google Scholar]
  • 18. Markesbery WR, Lovell MA (1998) Four‐hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19: 33–36. [DOI] [PubMed] [Google Scholar]
  • 19. Martinez MC, Bosh‐Morell F, Raya A, Roma J, Aldasoro M, Vila J, Lluch S, Romero FJ (1994) 4‐Hydroxynonenal, a lipid peroxidation product, induces relaxation of human cerebral arteries. J Cereb Blood Flow Metab 14: 693–696. [DOI] [PubMed] [Google Scholar]
  • 20. Mattson MP, Weiming F, Weag G, Uchida K (1997) 4‐Hydroxynonenal, a lipid peroxidation, inhibits dephosphorylation of the microtubule‐associated protein tau. NeuroReport 8: 2275–2281. [DOI] [PubMed] [Google Scholar]
  • 21. McCracken E, Jover T, McCulloch J, Dewar D (2000) The lipid peroxidation product, 4‐hydroxynonenal, is toxic to oligodendroctyes in vitro and white matter in vivo . J Cereb Blood Flow Met 11: 1529–1536. [DOI] [PubMed] [Google Scholar]
  • 22. Miyata M, Smith JD (1996) Apolipoprotein E allele specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta amyloid peptides. Nature Gen 14:55–61. [DOI] [PubMed] [Google Scholar]
  • 23. Montine TJ, Amaranath V, Martin ME, Strittmatter WJ, Graham DG (1996) E‐4‐hydroxy‐2‐nonenal is cytotoxic and cross‐links cytoskeletal proteins in P19 neuroglia cultures. Am J Pathol 148: 89–93. [PMC free article] [PubMed] [Google Scholar]
  • 24. Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG, Montine TJ (1997) Immunohistochemical detection of 4‐hydroxy‐2‐nonenal adducts in Alzheimer's Disease is associated with inheritance of APOE4. Am J Path 150: 437–444. [PMC free article] [PubMed] [Google Scholar]
  • 25. Montine KS, Kim PJ, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ (1997) 4‐Hydroxynonenal‐2‐nonenal pyrrole adducts in human neurodegenerative disease. J Neuropath Exp Neurol 56: 866–871. [DOI] [PubMed] [Google Scholar]
  • 26. Montine KS, Reich E, Neely MR, Disell KR, Olson SJ, Markesbery WR, Montine TJ (1998) Distribution of reducible 4‐hydroxynonenal adduct immunoreactivity in Alzheimer Disease is associated with APOE Genotype. J Neuropath Exp Neurol 57: 415–425. [DOI] [PubMed] [Google Scholar]
  • 27. Neely AN, Sidell KR, Graham DG, Montine TJ (1999) The lipid peroxidation product 4‐hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J Neurochem 72: 2323–2333. [DOI] [PubMed] [Google Scholar]
  • 28. Nicoll JAR, Roberts GW, Graham DI (1995) Apolipoprotein E e4 allele is associated with deposition of amyloid beta‐protein following head injury. Nat Med 1:135–137. [DOI] [PubMed] [Google Scholar]
  • 29. Nicoll JAR, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV (1997). High frequency of apolipoprotein E e2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41: 716–721. [DOI] [PubMed] [Google Scholar]
  • 30. Pedersen WA, Chan SL, Mattson M (2000) A mechanism for the neuroprotective effect of apolipoprotein E: isoform specific modification by the lipid peroxidation product 4‐hydroxynonenal. J Neurochem 74: 1426–1433. [DOI] [PubMed] [Google Scholar]
  • 31. Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ (1999) 4‐Hydroxy‐2(E)‐nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem 72: 1617–1624. [DOI] [PubMed] [Google Scholar]
  • 32. Poli G, Schaur RJ (2000) 4‐Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50: 3115–3321. [DOI] [PubMed] [Google Scholar]
  • 33. Saunders AM, Strittmatter WJ, Schmechel D, GeorgeHyslop PH, Pericak‐Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper‐MacLachlan DR, Alberts MJ et al (1993) Association of apolipoprotein E allele epsilon 4 with lateonset familial and sporadic Alzheimer's disease. Neurology 43: 1467–1472. [DOI] [PubMed] [Google Scholar]
  • 34. Sayre LM, Zelasko DA, Harris PLR., Perry G, Salomon RG, Smith MA (1997) 4‐Hydroxynonenal‐derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68: 2092–2097. [DOI] [PubMed] [Google Scholar]
  • 35. Siems WG, Hapner SJ, Van Kuijk FJ (1996) 4‐Hydroxynonenal inhibits NaATPase. Free Radical Biol Med 20: 215–223. [DOI] [PubMed] [Google Scholar]
  • 36. Springer JE, Azbill RD, Mark RJ, Begley JG, Waeg G, Mattson MP (1997) 4‐Hydroxynonenal, a lipid peroxidation, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J Neurochem 6: 2469–2476. [DOI] [PubMed] [Google Scholar]
  • 37. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak‐Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform‐specific effects and implications for late‐onset Alzheimer's disease. Proc Natl Acad Sci USA 90: 8098–8102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak‐Vance M, Schmechel D, Roses AD (1994) Isoform‐specific interactions of apoE with microtubule associated protein tau: implications for AD. Proc Natl Acad Sci USA 91: 11183–11186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Subramanian R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield AD (1997) The lipid peroxidation product, 4‐hydroxy‐2‐trans‐nonenal alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 69: 1161–1169. [DOI] [PubMed] [Google Scholar]
  • 40. Teasdale GM, Nicoll JA, Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350: 1069–1071. [DOI] [PubMed] [Google Scholar]
  • 41. Uchida K, Itakura K, Kawakishi S, Hiai H, Toyokuni S, Stadtman ER (1995). Characterisation of epitopes recognised by 4‐hydroxy‐2‐nonenal specific antibodies. Arch Biochem Biophys 324: 241–248. [DOI] [PubMed] [Google Scholar]
  • 42. Urabe T, Hattori N, Yoshikawa M, Yoshino H, Uchida K, Mizuno Y (1998) Colocalisation of Bcl‐2 and 4‐hydroxynonenal modified proteins in microglia cells and neurons of rat brain following transient focal ischemia. Neurosci Lett 247: 159–162. [DOI] [PubMed] [Google Scholar]
  • 43. Xu PT, Schmechel D, Rothrock‐Christian T, Burkhart DS, Qiu HL, Popko B, Sullivan P, Maeda N, Saunders AM, Roses AD, Gilbert JR (1996) Human apolipoprotein E2, E3, and E4 isoform‐specific transgenic mice: human‐like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild‐type mice. Neurobiol Dis 3:229–245. [DOI] [PubMed] [Google Scholar]
  • 44. Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM (1998) Glial fibrillary acidic protein‐apoliprotein E (apoE) transgenic mice: astrocyte ‐specific expression and differing biological effects of astrocyte‐secreted apoE3 and apoE4 lipoproteins. J Neurosci 18: 3261–3271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Zhang D, Dhillon HS, Mattson MP, Yurek DM, Prasad RM (1999) Immunohistochemical detection of the lipid peroxidation product 4‐hydroxynonenal after experimental brain injury in the rat. Neurosci Lett 272: 57–61. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES